About this trial
The goal of this clinical trial is to learn if using calcium sulfate beads that contain vancomycin (an antibiotic) and pain-relieving medicines during spine surgery can improve recovery compared to standard care with intravenous (IV) morphine and local pain medicines.
Researchers want to know if the sustained release formulation of morphine from these calcium sulfate beads affect:
* Postoperative length of stay * Postoperative pain scores * Postoperative narcotic analgesic requirements
All participants in this study will already be scheduled to have spine surgery as part of their regular medical care. During surgery, participants will be assigned to receive either intraoperative placement of calcium sulfate beads with vancomycin alone or vancomycin with morphine and bupivacaine. All patients will still have access to standard of care with IV and PO pain regimens. Participants will then be followed after surgery to measure their pain, recovery, and medication use.
Participation is voluntary, and choosing not to join will not affect a person's medical care.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Able to understand and provide consent in English
Undergoing elective lumbar spinal decompression and fusion surgery at one or two levels
Disqualifiers
History of allergy or hypersensitivity to morphine, bupivacaine, or calcium sulfate.
Active systemic or localized infection at the surgical site.
History of chronic opioid dependence or opioid use disorder (as it may confound pain assessment).
Patients with severe renal or hepatic impairment (due to altered metabolism of analgesics and risk of complications from analgesic side effects).
Trial design
Treatments tested in this trial
- Vancomycin (local, via calcium sulfate beads)
- Morphine (local, via calcium sulfate beads)
- Bupivacaine (local, via calcium sulfate beads)
Treatment groups
Locations
Sponsors and collaborators
Ganesh M. Shankar
Lead sponsor
Massachusetts General Hospital
Sponsor institution